IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 1.55 (2012 - 2016).    Offical Sponser for International Conference in malaysia ,  https://www.icmhas.com/

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
PIPPHARMACON & IJPR 2018

PIPPHARMACON & IJPR 2018

Click to download
 

Article Detail

Label
Label
Cardiotonic Activity of Calotropis gigantea Leaf Extract against Doxorubicin Induced Congestive Cardiac Failure in Rats

Author: MOHAMMAD AZAMTHULLA*, ANBU J, ANITA MURALI, NEELAKANTA REDDY
Abstract: Calotropis gigantea is an important medicinal plant widely distributed throughout India. Due to the presence of various phytoconstituents, the present research was focused to evaluate the cardiotonic activity of C. gigantea leaf extract (CGLE) againstDoxorubicin induced cardiac failure. The dried leaf part of C. gigantea was extracted with ethanol and yield was fond to be 10.25% W/W.In-vitro cardiotonic activity of CGLE was studied by using Langendorff’s apparatus. Heart failure is represented by using HRLS and the effect of CGLE was studied by treatingwith different concentrations. In in-vivo study, Doxorubicin (2mg/kg, i.p) for 7 days was usedto induce cardiotoxicity and the protective effect of CGLE at dose 200 and 400 mg/kg wascompared with standard drug Digoxin. The parameters like ECG, serum CPK, SGOT, LDH and Histopathology of Heart tissue were evaluated. Cardiac enzyme & Cytosolic Ca2+ level inCGLE alone treated were studied using dose of 200 and 400 mg/kg daily for 15 days. In In-vitro study, CGLE at 10 mg/ml showed a significant increase in force ofcontraction, cardiac output and heart rate in the failing heart. In-vivo study revealed thatCGLE 400 mg/kg showed more significant protection by decrease in RR and QT intervals in ECG, serum CPK, SGOT and LDH levels were significantly reduced and histopathologicalstudies showed improvement myocardial tissue. Treatment with CGLE alone doesn’t showed increase cardiac enzyme & cytosolic Ca2+ level. Thus the study revealed that C.gigantea leaf extract possess significant cardiotonic activity against doxorubicin inducedheart failure.
Keyword: Cardiotonic activity, C.Gigantea, Doxorubicin, Heart failure
EOI: http://eoi.citefactor.org/10.11209/ijpr.10.03.005
DOI: https://doi.org/10.31838/ijpr/2018.10.03.034
Download: Request For Article
 












USER LOGIN


Username
Password
Login | Register
AICTE INTERNATIONAL CONFERENCE

AICTE Sponsored International Conference on Challenges, Opportunities and Newer Directions of Pharmacovigilance and Clinical Research in India

Download Brochure


For More Detail Visit www.pippharmacon.org
News & Events
SCImago Journal & Country Rank
hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477